SGLT2 inhibitor empagliflozin could be a new treatment for children with type 2 diabetes: lancet

Published Date: 04 Mar 2023

United States: Empagliflozin could be a new treatment option for children and adolescents with type 2 diabetes, with phase 3 clinical trials showing...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

'Chemo brain' cognitive issues linked to poor lymphatic-system drainage

2.

Study finds 1 in 12 patients labeled as having 'benign' results actually had high-risk prostate cancer

3.

Novel biomarkers may improve diagnosis of gallbladder cancer

4.

More evidence links physical activity with improved cancer survival

5.

Frontline Mosunetuzumab Shows High Response Rates in Follicular Lymphoma


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot